Skin problems with Mounjaro injections and how to deal with them | Causes of and measures for redness, swelling and itching

  • Published:
  • Updated:
  • Written by the Hiro Clinic Medical Weight Loss editorial team
  • 43 min read
Medically reviewed by Dr. Hiroko Oka Reviewed byDr. Hiroko OkaCertified Member, Japanese Society of Internal Medicine Editorial policy
Skin problems with Mounjaro injections and how to deal with them | Causes of and measures for redness, swelling and itching

Key points first

  • To prevent skin problems, rotating injection sites and clean technique are essential.
  • If you have side effects or feel something is wrong, don’t judge for yourself; consult your doctor right away.
  • Rather than relying only on the medication, improving your diet, exercise and lifestyle habits at the same time can help prevent rebound weight gain.

Introduction

Key point

Most skin problems from Mounjaro injections can be prevented by changing the injection site each time and disinfecting thoroughly.

Obesity is a serious health issue that raises the risk of lifestyle-related diseases, and for people struggling with weight loss, the arrival of new medications with medically proven effects has attracted great interest. One that has been in the spotlight recently is Mounjaro (generic name: tirzepatide). It is a “dual agonist” that combines two actions—a GLP-1 receptor agonist and a GIP receptor agonist—and is expected to have a stronger weight loss effect than earlier medications.

However, no matter how effective a medication is, without understanding how to use it correctly and how to prevent skin problems, the risk of side effects or reduced effectiveness increases. This article explains, with supporting evidence, the knowledge you need for weight loss treatment with Mounjaro.

What is Mounjaro? Its place in weight loss treatment

Mounjaro is a GIP/GLP-1 dual receptor agonist used in medical weight loss, and a high weight loss effect can be expected with a once-weekly self-injection. It is a diabetes medication approved in the United States and Japan, but in recent years its use as an obesity treatment has also been expanding. In the SURMOUNT-1 trial, an average weight loss of nearly 20% after 72 weeks of treatment was reported, demonstrating an effect that is hard to achieve with diet restriction or exercise.

Another advantage is that it only requires a self-injection once a week, which makes it easy to continue. This is thought to be a major support for keeping up with weight loss and also helpful in preventing rebound weight gain.

Correct use: injection basics and schedule

To get the effects of Mounjaro safely, it is essential to follow three basics: storage, dose adjustment and choice of injection site. Here we summarize the points to keep in mind for daily self-injection from the perspective of preventing skin problems.

2-1. Storage

Mounjaro is a product that is sensitive to temperature changes. Please store it following the points below.

  • As a rule, store it in the refrigerator (2–8°C).
  • Do not freeze it. Freezing may cause the medication to lose its effectiveness.
  • The period it can be kept at room temperature is said to be about 3–4 weeks; beyond that, it is important to always keep it refrigerated.

2-2. Dosing schedule

The dose is adjusted step by step based on the doctor’s judgment.

  • Starting dose2.5 mg once weekly for 4 weeks.
  • Dose escalationWhile monitoring effects and side effects, the dose is adjusted step by step every 4 weeks to 5 mg, 7.5 mg, 10 mg, 12.5 mg, up to a maximum of 15 mg.

Rapid dose increases without a doctor’s guidance should be avoided.

2-3. Injection site

How you choose the injection site is also directly linked to preventing skin problems.

  • Inject into the subcutaneous fat of the abdomen, thigh or upper arm.
  • As a rule, do not inject repeatedly into the same spot.

Skin problems that commonly occur with injections and how to prevent them

Mild skin reactions such as redness and itching are common with Mounjaro self-injections, but most can be prevented with correct technique. Let’s look at the symptoms that actually tend to occur and specific measures against them.

3-1. Common skin reactions

When Mounjaro is injected subcutaneously, mild reactions such as the following may occur.

  • Redness
  • Swelling
  • Itching
  • Lumps under the skin
  • Bruising

These often clear up within a few days, but they tend to get worse with repeated injections into the same spot. From what we hear in our practice, people who have made a habit of changing the injection site each time tend to report fewer skin problems.

3-2. Prevention

Most skin problems can be prevented with a little care when injecting. On social media, @shinjuku_y_diet has posted that “redness or discomfort at the injection site settles down in most cases as the body gets used to it, but this varies from person to person,” conveying the importance of regular checkups and close monitoring of your condition. Keep the following points in mind.

Change the injection site each time

Alternate between the left and right or upper and lower abdomen, the inner and outer thigh, and so on.

Disinfect thoroughly with an alcohol swab

This is the basic step to prevent skin infection.

Insert the needle straight (perpendicular)

Inserting at an angle tends to damage the skin and can cause bruising.

Consult a doctor if severe pain or widespread swelling persists

Because it may be an allergic reaction or infection, it is important not to judge for yourself but to see a medical institution.

Side effects to watch for when using Mounjaro

Mounjaro’s side effects are mainly gastrointestinal symptoms, but care is needed because they can rarely lead to serious conditions such as pancreatitis or gallbladder disease. Beyond skin problems, you should also stay alert to changes in your physical condition.

4-1. Gastrointestinal side effects

The most common are nausea, diarrhea, constipation and loss of appetite. These tend to be strongest at the start of treatment and gradually improve as the body gets used to the medication.

4-2. Serious adverse reactions

Pancreatitis

Be careful if you have sudden abdominal pain or vomiting.

Gallstones or gallbladder disease

Seek medical care if you have upper abdominal pain with fever.

Hypoglycemia

The risk increases when used together with diabetes medications.

These are rare, but they can become serious if detected late, so you need to watch for changes in your condition at all times.

Long-term use and preparing for rebound weight gain

Key point

When Mounjaro is stopped, appetite tends to return, and without building a foundation of healthy lifestyle habits at the same time, the risk of rebound weight gain increases.

It shows a high weight loss effect while it is being taken, but in fact, overseas reports have observed cases in which weight returned rapidly starting a few weeks after stopping.

It is therefore essential to make improvements to what you eat (high protein, low fat, moderate carbohydrates) and regular exercise a habit while you are using Mounjaro. Rather than relying entirely on the medication, getting your lifestyle in order increases the chance of maintaining your weight after you stop.

Rebound weight gain

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

Using it safely in consultation with a doctor

Taking Mounjaro under a doctor’s supervision, with continuous checks of the dose and side effects, is an absolute requirement for safe treatment. It is often used as self-pay treatment, and casual use based on your own judgment should be avoided. To ensure an appropriate dose, management of side effects and regular tests, it is important that it is always given under a doctor’s supervision.

Also, because the risks change depending on your medical history and other medications, people with diabetes, heart disease or gastrointestinal disease need to be especially careful.

About self-pay treatment and off-label use

Self-pay treatment
Medical weight loss is self-pay treatment (paid in full by the patient) and is not covered by public health insurance.
Off-label use
Using medicines for weight management or weight loss may be off-label use, outside the indications approved in Japan.
Relief System for Adverse Drug Reactions
With off-label use, health damage such as a serious side effect may not be covered by Japan’s Relief System for Adverse Drug Reactions.
Individual differences and the doctor’s judgment
Effects and side effects vary from person to person. A doctor decides after a consultation whether you can use a medicine and which medicine and dose are appropriate. Please tell us in advance about any symptoms, chronic conditions or medicines you are taking.

Common questions about injections: Q&A

Here we answer questions about injection technique and changes in physical condition that we are often asked in our practice. If you have any concerns, don’t judge for yourself; consult your doctor.

QIs there a way to reduce injection pain?
A

Injection pain depends on the needle angle and the injection speed. Tips for reducing pain are as follows.

  • Use medication that has been brought to room temperature (cold medication tends to increase pain).
  • Gently pinch the skin to lift the fat, and insert the needle straight into that area.
  • Injecting steadily at a constant speed is said to cause less pain than pushing it in slowly.
QWhat should I do if an injection mark remains?
A

If bruising or a lump remains, cooling or light massage may help it recover faster. However, rubbing hard can make it worse, so be careful. If it does not improve after a few days, consult your doctor.

QIs it OK to drink alcohol?
A

You can drink alcohol while using Mounjaro, but alcohol increases appetite and risks disrupting blood sugar control. Especially if you are using it to treat obesity, it can cancel out the weight loss effect, so ideally you should limit it as much as possible.

QDoes it affect the menstrual cycle or other changes in women’s health?
A

At present, there are no reports that it has a major effect on the menstrual cycle itself. However, nausea or changes in appetite may be stronger along with changes in hormonal balance, so it is recommended that you continue while monitoring your condition and consulting your doctor.

Lifestyle points to note besides skin problems

To make the most of Mounjaro’s effects, it is important to review what you eat, build a light exercise habit, and let go of psychological impatience. Here we explain how to build lifestyle habits that don’t rely solely on the action of the medication.

8-1. Balance with your diet

Mounjaro has a strong appetite-suppressing effect, so the amount you eat naturally decreases. However, extreme food restriction also makes it easier to lose muscle mass.

  • Make a conscious effort to eat high-protein foods (meat, fish, beans).
  • Don’t cut carbohydrates drastically; keep them in reasonable balance.
  • Drink enough fluids to prevent constipation and dehydration.

8-2. Building an exercise habit

Rather than relying only on medication, making light exercise a habit allows you to burn fat and maintain muscle strength. In particular, a combination of strength training and aerobic exercise is said to be most effective for preventing rebound weight gain.

8-3. The importance of psychological support

Mounjaro is attracting attention as a “weight loss drug,” but psychological dependence and excessive expectations are also risks. Even if weight loss plateaus, don’t be impatient; an attitude of sticking with it is important.

Tips for choosing a medical institution

To continue Mounjaro safely, it is important to choose a clinic based on three points: the doctor’s experience with the medication, transparency of costs, and a system for regular testing. Here we summarize the points to check when choosing a medical institution.

9-1. The doctor’s experience and support system

Because Mounjaro is a relatively new medication, it is reassuring to start under a doctor with ample experience using it. More clinics are also offering online consultation, but what matters is whether there is a system that lets you consult right away when side effects occur. In our experience, it is not uncommon for skin problems to “get worse while I was waiting to see how it went,” so we hope you will not hesitate to contact us early.

9-2. Checking costs

At present, Mounjaro is mainly prescribed as self-pay treatment. The price per pen differs between clinics, ranging widely from about ¥20,000 to ¥60,000 per month. You need to compare cost and effectiveness calmly and choose a plan you can continue over the long term.

9-3. Testing and follow-up system

It is advisable to choose a clinic that performs regular blood tests (liver function, kidney function, blood sugar, etc.). Continuing regular tests leads to early detection of side effects and makes it easier to continue treatment safely.

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

Future outlook and research trends

Mounjaro is a medication whose research is expected to expand further, not only for its weight loss effect but also for applications such as cardiovascular disease and fatty liver. It is attracting worldwide attention in the field of obesity treatment, and research such as the following is under way.

Prevention of cardiovascular disease

Improvements in high blood pressure and dyslipidemia accompanying weight loss have also been reported.

Application to fatty liver treatment

Effectiveness is expected in patients with nonalcoholic fatty liver disease (NAFLD/NASH).

Comparative trials with other GLP-1 drugs

Clinical trials directly comparing it with drugs such as semaglutide are under way to clarify which is safer and more effective.

As this latest knowledge accumulates, the ways Mounjaro is used and the range of its indications may expand further.

Not sure? Talk to us

No consultation fee (first & follow-up visits)Online consultation available

Toll-free 0120-241-929 (toll-free in Japan, 9:00–18:00 JST, Japanese only)

See prices

Summary

Most skin problems with Mounjaro can be prevented by thoroughly rotating injection sites and using clean technique. This article has covered everything from basic use to preventive measures; while it has a strong weight loss effect, it is also a medication that requires attention to side effects such as skin problems and gastrointestinal symptoms. The most important thing is to “use it correctly under a doctor’s guidance.”

  • To prevent skin problems, rotating injection sites and clean technique are essential.
  • If you have side effects or feel something is wrong, don’t judge for yourself; consult your doctor right away.
  • Rather than relying only on the medication, improving your diet, exercise and lifestyle habits at the same time can help prevent rebound weight gain.

Mounjaro is not just a “weight loss drug” but a treatment partner that supports improvements in lifestyle habits. Use it safely with the right knowledge, and aim for a healthy body over the long term.

References

This article was prepared under medical supervision with reference to the following academic literature, package inserts and official materials.

  • Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205–216. (SURMOUNT-1 trial)
  • Ludvik B, et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in type 2 diabetes (SURPASS-3). Lancet. 2021;398(10300):583–598.
  • Eli Lilly Japan K.K. “Mounjaro® subcutaneous injection: Interview Form” (2023) (Japanese).
  • Japan Diabetes Society. “Treatment Guide for Diabetes 2023.” Nankodo (Japanese).
  • Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384:989–1002. (for comparison with GLP-1 drugs)
  • Wall Street Journal. What Happened After I Stopped Taking a Weight-Loss Drug. 2023.
  • Rubino DM, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414–1425.
  • Garvey WT, et al. Efficacy and Safety of Tirzepatide in Adults With Type 2 Diabetes and Obesity: A Pooled Analysis of SURPASS Clinical Trials. Diabetes Obes Metab. 2023;25(1):41–52.
  • Japanese Dermatological Association. “Guidelines on Management of Subcutaneous Injection Sites” (revised edition) (Japanese).

Medically reviewed by: Dr. Hiroko Oka (Chair, Fukubikai Medical Corporation / Certified Member, Japanese Society of Internal Medicine)

Who to contact if you have side effects | When to seek care

If any of the following symptoms occur, please contact us rather than waiting to see on your own. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly gastrointestinal symptoms. Most are mild, but serious ones occur in rare cases.

SymptomPossible causeWhat to do
Persistent nausea or vomitingGastrointestinal symptoms; the most common side effectContact us if you continue to be unable to keep fluids down
Severe abdominal pain (pain that radiates to the back)Possible acute pancreatitisStop the medication immediately and seek medical care
Cold sweat, palpitations, intense hunger, feeling confused or drowsyHypoglycemiaTake sugar right away and contact us
Skin rash, difficulty breathing, swelling of the face or throatAllergic reactionSeek medical care immediately
Contact: 0120-241-929 (hours 9:00–18:00)

If your symptoms are severe outside these hours, please go to a nearby emergency medical facility.

Direct phone numbers for each clinic are listed on the clinic information page.

References

The information about medications in this article is based on the following official sources. For details on dosage and administration and side effects, always check the latest electronic package insert.
Pharmaceuticals and Medical Devices Agency (PMDA): “Mounjaro Subcutaneous Injection Ateos, electronic package insert” (Japanese)
PMDA: “Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos” (PDF, Japanese)
Ministry of Health, Labour and Welfare: “Prevention of lifestyle-related diseases” (Japanese)

When Mounjaro is used for purposes other than obesity disease, it is self-pay treatment and is not covered by public health insurance. Effects and side effects vary from person to person.

Reviewing doctor: Hiroko Oka
Reviewing doctor

Hiroko OkaDirector, Hiro Clinic Kawaguchi (physician)

Japanese Society of Internal Medicine About our medical review and editorial policy

You may also like

Back to all articles

Ask our AI chat AI chat